Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1397301

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1397301

Microneedle Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

According to a newly-released analysis report by Fairfield Market Research, the global Microneedle Drug Delivery Systems Market reached a valuation of US$ 6.6 Billion in 2024. The market is anticipated to soar to a valuation of US$ 10.5 Billion by 2031. Hollow Microneedle Drug Delivery Systems are expected to be the leading revenue-generating segment, with an estimated CAGR of 6% during the forecast period.

Overview of Microneedle Drug Delivery Systems

Microneedles, measuring in millionths of a meter, offer significant advantages over conventional needles and syringes for the delivery of biological agents. These tiny needles find applications in various fields, including dermatology, neurology, cardiology, oncology, and across the pharmaceutical, biotechnology, and medical industries.

Driving Factors for the Microneedle Drug Delivery Systems Market

Several factors are propelling the growth of the Microneedle Drug Delivery Systems Market, including:

  • Safer Alternatives: Microneedle Drug Delivery Systems provide safer alternatives to traditional hypodermic injections, addressing safety concerns.
  • Efficient Vaccination: The ease of vaccinating against diseases, such as measles, has gained popularity, making microneedle drug delivery systems increasingly used. These systems can be applied safely and effectively even by individuals without medical training.
  • Growing Safety Concerns: Safety issues, both short-term and long-term, are influencing healthcare administrators, clinical practitioners, patients, and regulators to seek safer alternatives to conventional injections, boosting research and development initiatives.
  • Advancements in Microneedle Patches: Microneedle patches are evolving, with expanded applications in hormone replacement, pain management, and congestive heart failure, contributing to market growth.

Challenges for the Microneedle Drug Delivery Systems Market

Despite its growth potential, the Microneedle Drug Delivery Systems Market may face challenges such as drug degradation, local discomfort, poor absorption, and absorption variability.

Key Market Revenue Center

The United States holds a prominent position in the Microneedle Drug Delivery Systems Market due to its extensive applications across various fields, including vaccine administration, hormonal delivery, cancer therapy, pain management, and cosmetics. The impact of the COVID-19 pandemic accelerated the adoption of non-invasive and painless microneedle drug delivery devices, further driving market growth.

Competitive Landscape

Key players operating in the Microneedle Drug Delivery Systems Market include: Raphas Co. Ltd., Becton Dickinson and Company, NanoPass Technologies Limited, 3M, Zosano Pharma Corporation, Corium International Inc., Valeritas Inc., Nitto Denko Corporation, Microdermics Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co. Ltd., and Small Lab.

Key Companies Profiled

  • Raphas Co. Ltd.
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Microneedle Drug Delivery Systems Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 3.1. Global Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Solid
      • 3.1.1.2. Hollow
      • 3.1.1.3. Dissolving
      • 3.1.1.4. Coated
      • 3.1.1.5. Other Types
  • 3.2. Global Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Silicon
      • 3.2.1.2. Metal
      • 3.2.1.3. Polymer
      • 3.2.1.4. Other Materials
  • 3.3. Global Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Dermatology
      • 3.3.1.2. Drug Delivery
      • 3.3.1.3. Pain Management
      • 3.3.1.4. Cancer Therapy
      • 3.3.1.5. Vaccine Delivery
      • 3.3.1.6. Other Applications
  • 3.4. Global Microneedle Drug Delivery Systems Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 4.1. North America Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Solid
      • 4.1.1.2. Hollow
      • 4.1.1.3. Dissolving
      • 4.1.1.4. Coated
      • 4.1.1.5. Other Types
  • 4.2. North America Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Silicon
      • 4.2.1.2. Metal
      • 4.2.1.3. Polymer
      • 4.2.1.4. Other Materials
  • 4.3. North America Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Dermatology
      • 4.3.1.2. Drug Delivery
      • 4.3.1.3. Pain Management
      • 4.3.1.4. Cancer Therapy
      • 4.3.1.5. Vaccine Delivery
      • 4.3.1.6. Other Applications
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 5.1. Europe Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Solid
      • 5.1.1.2. Hollow
      • 5.1.1.3. Dissolving
      • 5.1.1.4. Coated
      • 5.1.1.5. Other Types
  • 5.2. Europe Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Silicon
      • 5.2.1.2. Metal
      • 5.2.1.3. Polymer
      • 5.2.1.4. Other Materials
  • 5.3. Europe Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Dermatology
      • 5.3.1.2. Drug Delivery
      • 5.3.1.3. Pain Management
      • 5.3.1.4. Cancer Therapy
      • 5.3.1.5. Vaccine Delivery
      • 5.3.1.6. Other Applications
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Solid
      • 6.1.1.2. Hollow
      • 6.1.1.3. Dissolving
      • 6.1.1.4. Coated
      • 6.1.1.5. Other Types
  • 6.2. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Silicon
      • 6.2.1.2. Metal
      • 6.2.1.3. Polymer
      • 6.2.1.4. Other Materials
  • 6.3. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Dermatology
      • 6.3.1.2. Drug Delivery
      • 6.3.1.3. Pain Management
      • 6.3.1.4. Cancer Therapy
      • 6.3.1.5. Vaccine Delivery
      • 6.3.1.6. Other Applications
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 7.1. Latin America Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Solid
      • 7.1.1.2. Hollow
      • 7.1.1.3. Dissolving
      • 7.1.1.4. Coated
      • 7.1.1.5. Other Types
  • 7.2. Latin America Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Silicon
      • 7.2.1.2. Metal
      • 7.2.1.3. Polymer
      • 7.2.1.4. Other Materials
  • 7.3. Latin America Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Dermatology
      • 7.3.1.2. Drug Delivery
      • 7.3.1.3. Pain Management
      • 7.3.1.4. Cancer Therapy
      • 7.3.1.5. Vaccine Delivery
      • 7.3.1.6. Other Applications
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Solid
      • 8.1.1.2. Hollow
      • 8.1.1.3. Dissolving
      • 8.1.1.4. Coated
      • 8.1.1.5. Other Types
  • 8.2. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Material, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Silicon
      • 8.2.1.2. Metal
      • 8.2.1.3. Polymer
      • 8.2.1.4. Other Materials
  • 8.3. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Dermatology
      • 8.3.1.2. Drug Delivery
      • 8.3.1.3. Pain Management
      • 8.3.1.4. Cancer Therapy
      • 8.3.1.5. Vaccine Delivery
      • 8.3.1.6. Other Applications
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Microneedle Drug Delivery Systems Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Material, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Microneedle Drug Delivery Systems Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Distribution Channel vs by Material Heat map
  • 9.2. Manufacturer vs by Material Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Raphas Co. Ltd.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Becton Dickinson and Company
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. NanoPass Technologies Limited
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. 3M
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Zosano Pharma Corporation
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Corium International Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Valeritas Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Nitto Denko Corporation
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Microdermics Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. TheraJect Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!